Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD.
作者信息
Elbaum Lindsay, Tomacruz Isabelle Dominique V, Bangalore Sripal
机构信息
Division of Cardiovascular Medicine, New York University, New York, New York, USA.
Division of Nephrology, Department of Medicine, Philippine General Hospital, University of the Philippines Manila, Metro Manila, Philippines.
出版信息
Kidney Int Rep. 2022 Nov 19;8(1):10-13. doi: 10.1016/j.ekir.2022.11.010. eCollection 2023 Jan.
Abstract
摘要
相似文献
1
Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD.慢性肾脏病患者冠状动脉微血管功能障碍的临床意义
Kidney Int Rep. 2022 Nov 19;8(1):10-13. doi: 10.1016/j.ekir.2022.11.010. eCollection 2023 Jan.
2
Coronary flow abnormalities in chronic kidney disease: A systematic review and meta-analysis.慢性肾脏病中的冠状动脉血流异常：系统评价和荟萃分析。
Echocardiography. 2022 Nov;39(11):1382-1390. doi: 10.1111/echo.15445. Epub 2022 Oct 5.
3
FGF23 impairs peripheral microvascular function in renal failure.成纤维细胞生长因子 23 可损害肾衰竭患者的外周微血管功能。
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1414-H1424. doi: 10.1152/ajpheart.00272.2018. Epub 2018 Jul 20.
4
Prognostic Impact of Coronary Flow Reserve in Patients With CKD.慢性肾脏病患者冠状动脉血流储备的预后影响
Kidney Int Rep. 2022 Oct 8;8(1):64-74. doi: 10.1016/j.ekir.2022.10.003. eCollection 2023 Jan.
5
Reduced nitric oxide bioavailability impairs myocardial oxygen balance during exercise in swine with multiple risk factors.多种危险因素致猪运动时一氧化氮生物利用度降低，心肌氧平衡受损。
Basic Res Cardiol. 2021 Aug 26;116(1):50. doi: 10.1007/s00395-021-00890-8.
6
Accelerated and intensified calcific atherosclerosis and microvascular dysfunction in patients with chronic kidney disease.慢性肾病患者加速且强化的钙化性动脉粥样硬化及微血管功能障碍
Rev Cardiovasc Med. 2020 Jun 30;21(2):157-162. doi: 10.31083/j.rcm.2020.02.99.
7
Coronary microvascular dysfunction in the clinical setting: from mystery to reality.临床中的冠状动脉微血管功能障碍：从谜团到现实。
Eur Heart J. 2012 Nov;33(22):2771-2782b. doi: 10.1093/eurheartj/ehs246. Epub 2012 Aug 22.
8
Coronary flow velocity reserve and inflammatory markers in living kidney donors.活体肾捐献者的冠状动脉血流储备和炎症标志物。
Int J Cardiol. 2020 Dec 1;320:141-147. doi: 10.1016/j.ijcard.2020.08.013. Epub 2020 Aug 14.
9
Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.无论慢性肾脏病阶段如何，冠状动脉血流储备均可预测心血管死亡风险。
Kidney Int. 2018 Feb;93(2):501-509. doi: 10.1016/j.kint.2017.07.025. Epub 2017 Oct 13.
10
Coronary microvascular function in early chronic kidney disease.早期慢性肾脏病的冠状动脉微血管功能。
Circ Cardiovasc Imaging. 2010 Nov;3(6):663-71. doi: 10.1161/CIRCIMAGING.110.957761. Epub 2010 Sep 17.
引用本文的文献
1
Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease.急性冠状动脉综合征合并慢性肾脏病患者中，通过自适应多分辨率分析评估的冠状动脉微血管功能障碍的预后影响。
Front Cardiovasc Med. 2025 Jan 7;11:1489403. doi: 10.3389/fcvm.2024.1489403. eCollection 2024.
2
Role of polyphenolic compounds and their nanoformulations: a comprehensive review on cross-talk between chronic kidney and cardiovascular diseases.多酚类化合物及其纳米制剂的作用：关于慢性肾脏疾病与心血管疾病之间相互作用的综合综述
Naunyn Schmiedebergs Arch Pharmacol. 2023 May;396(5):901-924. doi: 10.1007/s00210-023-02410-y. Epub 2023 Feb 24.
本文引用的文献
1
Prognostic Impact of Coronary Flow Reserve in Patients With CKD.慢性肾脏病患者冠状动脉血流储备的预后影响
Kidney Int Rep. 2022 Oct 8;8(1):64-74. doi: 10.1016/j.ekir.2022.10.003. eCollection 2023 Jan.
2
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估与诊断指南：美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2021 Nov 30;78(22):e187-e285. doi: 10.1016/j.jacc.2021.07.053. Epub 2021 Oct 28.
3
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.冠状动脉微血管功能障碍在心血管疾病谱中的表现：美国心脏病学会最新综述。
J Am Coll Cardiol. 2021 Sep 28;78(13):1352-1371. doi: 10.1016/j.jacc.2021.07.042.
4
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.慢性肾脏病中的心血管疾病：病理生理学见解与治疗选择。
Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.
5
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.一份由欧洲心脏病学会冠状动脉病理生理学与微循环工作组合作完成，并经冠状动脉血管舒缩障碍国际研究组认可的关于非阻塞性冠状动脉缺血的欧洲经皮心血管介入学会专家共识文件。
Eur Heart J. 2020 Oct 1;41(37):3504-3520. doi: 10.1093/eurheartj/ehaa503.
6
Management of Coronary Disease in Patients with Advanced Kidney Disease.晚期肾病患者的冠状动脉疾病管理。
N Engl J Med. 2020 Apr 23;382(17):1608-1618. doi: 10.1056/NEJMoa1915925. Epub 2020 Mar 30.
7
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review.冠状动脉微血管疾病的发病机制和治疗选择：美国心脏病学会最新综述。
J Am Coll Cardiol. 2018 Nov 27;72(21):2625-2641. doi: 10.1016/j.jacc.2018.09.042.
8
Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.无论慢性肾脏病阶段如何，冠状动脉血流储备均可预测心血管死亡风险。
Kidney Int. 2018 Feb;93(2):501-509. doi: 10.1016/j.kint.2017.07.025. Epub 2017 Oct 13.
9
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.腺苷介导的冠状动脉微血管反应性与疑似缺血女性患者的不良预后相关：来自美国国立心肺血液研究所 WISE（女性缺血综合征评估）研究的结果。
J Am Coll Cardiol. 2010 Jun 22;55(25):2825-32. doi: 10.1016/j.jacc.2010.01.054.
Zotero 插件